BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18375246)

  • 1. Tumor lymphangiogenesis and lymphangiogenic growth factors.
    Da MX; Wu Z; Tian HW
    Arch Med Res; 2008 May; 39(4):365-72. PubMed ID: 18375246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathways targeting tumor lymphangiogenesis.
    Wissmann C; Detmar M
    Clin Cancer Res; 2006 Dec; 12(23):6865-8. PubMed ID: 17145802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-derived lymphangiogenic factors and lymphatic metastasis.
    Cao Y; Zhong W
    Biomed Pharmacother; 2007 Oct; 61(9):534-9. PubMed ID: 17904785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor and lymph node lymphangiogenesis--impact on cancer metastasis.
    Tobler NE; Detmar M
    J Leukoc Biol; 2006 Oct; 80(4):691-6. PubMed ID: 16793912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor lymphangiogenesis and melanoma metastasis.
    Rinderknecht M; Detmar M
    J Cell Physiol; 2008 Aug; 216(2):347-54. PubMed ID: 18481261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-induced lymphangiogenesis: a target for cancer therapy?
    Thiele W; Sleeman JP
    J Biotechnol; 2006 Jun; 124(1):224-41. PubMed ID: 16497404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
    Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
    Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphangiogenesis, inflammation and metastasis.
    Schoppmann SF
    Anticancer Res; 2005; 25(6C):4503-11. PubMed ID: 16334134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphatic vessel activation in cancer.
    Das S; Skobe M
    Ann N Y Acad Sci; 2008; 1131():235-41. PubMed ID: 18519976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.
    Feng Y; Wang W; Hu J; Ma J; Zhang Y; Zhang J
    Anat Rec (Hoboken); 2010 May; 293(5):802-12. PubMed ID: 20225197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma.
    Niki T; Iba S; Tokunou M; Yamada T; Matsuno Y; Hirohashi S
    Clin Cancer Res; 2000 Jun; 6(6):2431-9. PubMed ID: 10873096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphangiogenesis and tumor metastasis: myth or reality?
    Pepper MS
    Clin Cancer Res; 2001 Mar; 7(3):462-8. PubMed ID: 11297234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis.
    Lohela M; Bry M; Tammela T; Alitalo K
    Curr Opin Cell Biol; 2009 Apr; 21(2):154-65. PubMed ID: 19230644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of tumor cells and lymphatic vessels in cancer progression.
    Alitalo A; Detmar M
    Oncogene; 2012 Oct; 31(42):4499-508. PubMed ID: 22179834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor C promotes lymph node metastasis in a rectal cancer orthotopic model.
    Kawakami M; Yanai Y; Hata F; Hirata K
    Surg Today; 2005; 35(2):131-8. PubMed ID: 15674494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of vascular endothelial growth factors (VEGF)-A, -C and -D and their prognostic significance and relationship with angio- and lymphangiogenesis in gastric cancer].
    Wang XL; Ai ZS; Fang JP; Tang RY; Chen XM
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):837-43. PubMed ID: 19173829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis.
    Ruddell A; Kelly-Spratt KS; Furuya M; Parghi SS; Kemp CJ
    Oncogene; 2008 May; 27(22):3145-55. PubMed ID: 18059331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphatic vessels and lymphangiogenesis in female cancer: mechanisms, clinical impact and possible implications for anti-lymphangiogenic therapies (Review).
    Schoppmann SF; Horvat R; Birner P
    Oncol Rep; 2002; 9(3):455-60. PubMed ID: 11956609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-C and lymph node metastases in human prostate cancer.
    Di JM; Zhou J; Zhou XL; Gao X; Shao CQ; Pang J; Sun QP; Zhang Y; Ruan XX
    Arch Med Res; 2009 May; 40(4):268-75. PubMed ID: 19608016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.